The Physician Office Diagnostic Testing Market To Re-Ignite With Innovation In The Next Decade

Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both.

Symptoms of Diabetes are hyperglycemic conditions, excessive excretion of urine, hunger, thirst, weight loss, fatigue and impaired vision. Diabetes is classified into Type 1 and Type 2 Diabetes. According to 2014 statistics of WHO, globally 422 million people are suffering from diabetes with a prevalence rate of 8.5%.

Insulin therapy is the first line treatment for the diabetes if the patients didn't respond to the oral hypoglycemic agents for type 2 diabetes. Insulin is usually administered via submucosal route by using insulin injections for both type 1 and type 2 diabetes.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/12388

In diabetes diagnosis, blood pricking is the usual procedure to analyse the blood glucose levels in the body. This conventional treatment and diagnosis procedures might cause the needle-stick injuries for healthcare professionals and carers that leads to various infections and pain. Hence, non-invasive needle-free diabetes products gained traction in these years to overcome the aforementioned problems and to reduce needle phobia conditions in patients.

With an increase in the aging population, prevalence of diabetes population, raise in obese population, and change in food habits are the factors driving the growth of the needle-free diabetes care market during the forecast period. In addition to that, increase in awareness about the diabetes disease conditions are also driving the market.

However, incorrect dosage, instances of skin damage or pain, infections, high cost and technical errors might hamper the growth of this needle-free diabetes care market during the forecast period.

For entire list of market players, request for Table of content here @ https://www.persistencemarketresearch.com/toc/12388

Market Segmentation
Based on devices
• Treatment devices
o Insulin patches
o Jet Injectors
o Insulin pens
o Insulin pumps
o Insulin infuser
• Diagnostic devices
o Continuous glucose monitoring
o Instant glucose monitoring

Based on end user
• Diagnostic Centers
• Hospitals and Clinics
• Consumer

Regional Outlook
Depending on the geographic region, needle-free diabetes care market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America is expected to have highest revenue share in needle-free diabetes care market and Asia Pacific geography is expected to dominate the market in future due to increase in the prevalence of diabetes population, especially in China and India.

Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/12388

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.